价格

NEURAXPHARM PHARMACEUTICALS S.L.

ACTIVE

AVENIDA BARCELONA 69, Sant Joan Despi, Barcelona, 西班牙Private

别名:

laboratorios lesvi, s.l.

概览

试验阶段分布

阶段

试验数

占比

3 期

66.7%

1 期

33.3%

试验状态分布

招募中

100.0%

药物批准

按机构分类的批准

EMA

European Medicines Agency

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

Azithromycin film-coated tablets 500mg Lesvi Lab

NPRA

2025-11-28

Azithromycin Powder For Oral Suspension 200mg/5ml Lesvi Lab

RIULVY 174 MG CAPSULAS DURAS GASTRORRESISTENTES

CIMA_AEMPS

2025-09-05

RIULVY 348 MG CAPSULAS DURAS GASTRORRESISTENTES

PAXNEURY 1 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

CIMA_AEMPS

2025-03-19

PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA

CIMA_AEMPS

2025-03-19

PAXNEURY 3 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

CIMA_AEMPS

2025-03-19

资讯

暂无资讯文章

返回机构列表

NEURAXPHARM PHARMACEUTICALS S.L.

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（3）

Study to Evaluate the Efficacy and Safety Levetiracetam in Patients with Epilepsy

Safety Study to Compare the Gastrointestinal Tolerability of Oral Tegomil Fumarate and Dimethyl Fumarate (Tecfidera®) in Healthy Volunteers.

Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures

药物批准

按机构分类的批准

近期批准

资讯